https://ift.tt/3muub1k Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India (DCGI)...
COVID-19 vaccine: Zydus Cadila gets DGCI nod for phase 3 clinical trials of Pegylated Interferon Alpha-2
Reviewed by MITESH
on
December 03, 2020
Rating: 5